(Q34132390)

English

Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2

object named as

Chad Bousman

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9

object named as

Igor Grant

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5

object named as

Scott Letendre

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Robert K Heaton

8

object named as

Robert Heaton

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Mariana Cherner

1

object named as

Mariana Cherner

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

object named as

Florin Vaida

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

10

object named as

HNRC Group

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Daniel S Barron

4

object named as

Daniel Barron

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Ian Everall

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J Hampton Atkinson

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

23 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Journal of the International Neuropsychological Society

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

890-901

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Bioavailability of (+)-methamphetamine in the pigeon following an intramuscular dose

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Neurocognitive effects of methamphetamine: a critical review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Determination of amphetamine, methamphetamine, and hydroxyamphetamine derivatives in urine by gas chromatography-mass spectrometry and its relation to CYP2D6 phenotype of drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Demographically corrected norms for the Brief Visuospatial Memory Test-revised and Hopkins Verbal Learning Test-revised in monolingual Spanish speakers from the U.S.-Mexico border region

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine ('Ecstasy') cytotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Causes and consequences of methamphetamine and MDMA toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Pharmacogenetics of cytochrome p4502D6: genetic background and clinical implication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Reduction of amphetamine hydroxylamine and other aliphatic hydroxylamines by benzamidoxime reductase and human liver microsomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Attention and memory in illicit amphetamine users: comparison with non-drug-using controls

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Attention and memory in illicit amphetamine users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Interactions of amphetamine analogs with human liver CYP2D6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

The metabolic fate of amphetamine in man and other species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Identification of the primary gene defect at the cytochrome P450 CYP2D locus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Comparative Metabolism of the Amphetamine Drugs of Dependence in Man and Monkeys

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

5 July 2018

Metabolism of [14C]methamphetamine in man, the guinea pig and the rat

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Cytochrome P450 II D6 gene polymorphisms and the neuroleptic-induced extrapyramidal symptoms in Japanese schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Polymorphism in environment responsive genes and association with Parkinson disease

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

An exploratory study: the use of paroxetine for methamphetamine craving

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1355617710000779

21 January 2018

Detoxication gene polymorphism and susceptibility to sporadic motor neuron disease in Russian population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

28 October 2018

Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

28 October 2018

Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

28 October 2018

Genetic analysis of the CYP2D locus in relation to debrisoquine hydroxylation capacity in Korean, Japanese and Chinese subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

28 October 2018

Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543816

28 October 2018

Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20727252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20727252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6

1 reference

https://pubmed.ncbi.nlm.nih.gov/20727252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Necrotizing angiitis associated with drug abuse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20727252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebral Vascular Changes Secondary to Amphetamine Abuse in the Experimental Animal

1 reference

https://pubmed.ncbi.nlm.nih.gov/20727252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic differences in spatial learning between Dark Agouti and Sprague-Dawley strains: possible correlation with the CYP2D2 polymorphism in rats treated neonatally with methamphetamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20727252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/20727252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary excretion of the main metabolites of methamphetamine, including p-hydroxymethamphetamine-sulfate and p-hydroxymethamphetamine-glucuronide, in humans and rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/20727252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1017/S1355617710000779

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34132390&oldid=1740013913"